90 related articles for article (PubMed ID: 20506166)
21. The expression of multiple proto-oncogenes is differentially regulated during retinoic acid induced maturation of human neuroblastoma cell lines.
Thiele CJ; Deutsch LA; Israel MA
Oncogene; 1988 Sep; 3(3):281-8. PubMed ID: 3060792
[TBL] [Abstract][Full Text] [Related]
22. Morphologic conversion of a neuroblastoma-derived cell line by E6-mediated p53 degradation.
Gaitonde SV; Qi W; Falsey RR; Sidell N; Martinez JD
Cell Growth Differ; 2001 Jan; 12(1):19-27. PubMed ID: 11205742
[TBL] [Abstract][Full Text] [Related]
23. Aberrant expression and localization of hnRNP-A2/B1 is a common event in human gastric adenocarcinoma.
Jing GJ; Xu DH; Shi SL; Li QF; Wang SY; Wu FY; Kong HY
J Gastroenterol Hepatol; 2011 Jan; 26(1):108-15. PubMed ID: 21175803
[TBL] [Abstract][Full Text] [Related]
24. Fos and Jun form cell specific protein complexes at the neuropeptide tyrosine promoter.
Jalava A; Mai S
Oncogene; 1994 Aug; 9(8):2369-75. PubMed ID: 8036020
[TBL] [Abstract][Full Text] [Related]
25. Schedule-dependent sphinganine potentiation of retinoic acid-induced differentiation, cell growth inhibition, and nucleophosmin translocation in a human leukemia cell line (HL-60).
Hui EK; Yang YH; Yung BY
Exp Hematol; 1992 May; 20(4):454-61. PubMed ID: 1568462
[TBL] [Abstract][Full Text] [Related]
26. Resistance to geldanamycin-induced apoptosis in differentiated neuroblastoma SH-SY5Y cells.
Shen JH; Zhang Y; Wu NH; Shen YF
Neurosci Lett; 2007 Mar; 414(2):110-4. PubMed ID: 17293044
[TBL] [Abstract][Full Text] [Related]
27. Bcl-2 expression in neuroblastoma is differentially regulated by differentiation inducers.
Kim CJ; Kim HO; Choe YJ; Lee YA; Kim CW
Anticancer Res; 1995; 15(5B):1997-2000. PubMed ID: 8572591
[TBL] [Abstract][Full Text] [Related]
28. Programmed cell death-4 tumor suppressor protein contributes to retinoic acid-induced terminal granulocytic differentiation of human myeloid leukemia cells.
Ozpolat B; Akar U; Steiner M; Zorrilla-Calancha I; Tirado-Gomez M; Colburn N; Danilenko M; Kornblau S; Berestein GL
Mol Cancer Res; 2007 Jan; 5(1):95-108. PubMed ID: 17259349
[TBL] [Abstract][Full Text] [Related]
29. Effects of all-trans-retinoic acid on human SH-SY5Y neuroblastoma as in vitro model in neurotoxicity research.
Cheung YT; Lau WK; Yu MS; Lai CS; Yeung SC; So KF; Chang RC
Neurotoxicology; 2009 Jan; 30(1):127-35. PubMed ID: 19056420
[TBL] [Abstract][Full Text] [Related]
30. Enhanced potency of 9-cis versus all-trans-retinoic acid to induce the differentiation of human neuroblastoma cells.
Han G; Chang B; Connor MJ; Sidell N
Differentiation; 1995 Jul; 59(1):61-9. PubMed ID: 7589896
[TBL] [Abstract][Full Text] [Related]
31. Induction of transforming growth factor beta 1 and its receptors during all-trans-retinoic acid (RA) treatment of RA-responsive human neuroblastoma cell lines.
Cohen PS; Letterio JJ; Gaetano C; Chan J; Matsumoto K; Sporn MB; Thiele CJ
Cancer Res; 1995 Jun; 55(11):2380-6. PubMed ID: 7757990
[TBL] [Abstract][Full Text] [Related]
32. Heterogeneity in retinoic acid signaling in neuroblastomas: Role of matrix metalloproteinases in retinoic acid-induced differentiation.
Joshi S; Guleria RS; Pan J; Dipette D; Singh US
Biochim Biophys Acta; 2007 Sep; 1772(9):1093-102. PubMed ID: 17611083
[TBL] [Abstract][Full Text] [Related]
33. c-Myc-mediated expression of nucleophosmin/B23 decreases during retinoic acid-induced differentiation of human leukemia HL-60 cells.
Yung BY
FEBS Lett; 2004 Dec; 578(3):211-6. PubMed ID: 15589822
[TBL] [Abstract][Full Text] [Related]
34. Ouabain-Induced Signaling and Cell Survival in SK-N-SH Neuroblastoma Cells Differentiated by Retinoic Acid.
Akkuratov EE; Wu J; Sowa D; Shah ZA; Liu L
CNS Neurol Disord Drug Targets; 2015; 14(10):1343-9. PubMed ID: 26295826
[TBL] [Abstract][Full Text] [Related]
35. Alteration of nuclear matrix-intermediate filament system and differential expression of nuclear matrix proteins during human hepatocarcinoma cell differentiation.
Tang J; Niu JW; Xu DH; Li ZX; Li QF; Chen JA
World J Gastroenterol; 2007 May; 13(20):2791-7. PubMed ID: 17569113
[TBL] [Abstract][Full Text] [Related]
36. Status of topoisomerase-2β protein in all-trans retinoic acid-treated human neuroblastoma (SK-N-SH) cells.
Bhanothu V; Kondapi AK
J Cell Biochem; 2019 Apr; 120(4):5169-5182. PubMed ID: 30318608
[TBL] [Abstract][Full Text] [Related]
37. Retinoic acid-induced differentiation of human neuroblastoma: a cell variant system showing two distinct responses.
Sidell N; Sarafian T; Kelly M; Tsuchida T; Haussler M
Exp Cell Biol; 1986; 54(5-6):287-300. PubMed ID: 3026862
[TBL] [Abstract][Full Text] [Related]
38. MicroRNAs-10a and -10b contribute to retinoic acid-induced differentiation of neuroblastoma cells and target the alternative splicing regulatory factor SFRS1 (SF2/ASF).
Meseguer S; Mudduluru G; Escamilla JM; Allgayer H; Barettino D
J Biol Chem; 2011 Feb; 286(6):4150-64. PubMed ID: 21118818
[TBL] [Abstract][Full Text] [Related]
39. Nuclear matrix protein, prohibitin, was down-regulated and translocated from nucleus to cytoplasm during the differentiation of osteosarcoma MG-63 cells induced by ginsenoside Rg1, cinnamic acid, and tanshinone IIA (RCT).
Shi SL; Li QF; Liu QR; Xu DH; Tang J; Liang Y; Zhao ZL; Yang LM
J Cell Biochem; 2009 Nov; 108(4):926-34. PubMed ID: 19725052
[TBL] [Abstract][Full Text] [Related]
40. Effect of retinoic acid on p21ras and regulators of its activity in neuroblastoma.
Burchill SA; Berry PA; Lewis IJ
Eur J Cancer; 1995; 31A(4):476-81. PubMed ID: 7576949
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
